KYomed INNOV / What's new / MASK-air app Winners of the 2nd Edition of Value Added Medicines Award
What's new
29 Nov 2019
MASK-air app Winners of the 2nd Edition of Value Added Medicines Award
Value added medicines conference urges paradigm shift across the healthcare access and regulatory landscape
Value added medicines deliver sustainable and continuous innovation with existing molecules and enhance patients’ well-being.
The 3rd Value Added Medicines Conference brought together thought leaders to discuss the future of digital delivery and the regulatory and market access framework for value added medicines, to help tackle chronic diseases and an ageing population.
According to IQVIA, value added medicines have grown 1% in volume in the EU over the last year, and many more initiatives are needed for improving patients’ access to value added medicines.
During the conference, a multi-stakeholder exchange of ideas identified clear next steps to improve patients’ access to value added medicines:
• Timely approval of value added medicines via streamlined scientific advice processes, fit-for-purpose trial designs and agreed approval pathways with tailor-made incentives for innovation.
• “Next generation guidelines” advised by physicians here.
• A pragmatic value framework that enables access to value added medicines and considers the specific benefits of value added medicines.
• The contribution of digital value added medicines in changing the paradigm of disease management and benefiting patients, healthcare professionals and healthcare systems.
The Value Added Medicines sector group instituted two awards for projects that bring value added solutions to patients.
The winners of the 2019 awards were:
Winner category “Scientific research/projects led by academics/healthcare professionals/developers that aim to improve existing treatment adherence and/or convenience and/or patients’ preferences and/or demonstrate relevant value added benefits for patients.”
Project “MASK digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice and value-added medicines”,
Health innovation and personalized medicine are our expertise. We may help you to accelerate the development of biomarkers, connected medical devices or digital healthcare solutions by bringing the right expertise at the right time.
You are a citizen, a patient, a care provider, or a healthcare professional, and you wish to reshape with us the future of healthcare? KYomed INNOV welcomes and value you as full partner in the health innovation process. Learn more about us and join our community.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPTReject
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
Value added medicines deliver sustainable and continuous innovation with existing molecules and enhance patients’ well-being.
